scholarly article | Q13442814 |
P356 | DOI | 10.1097/SLA.0B013E318254F281 |
P698 | PubMed publication ID | 22580940 |
P50 | author | Peter H. Cashin | Q50945433 |
Peter Nygren | Q66206118 | ||
P2093 | author name string | Haile Mahteme | |
Wilhelm Graf | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
peritoneal carcinomatosis | Q2071182 | ||
P304 | page(s) | 1078-1083 | |
P577 | publication date | 2012-12-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study. | |
P478 | volume | 256 |
Q87821321 | A new technique to improve surgery for peritoneal colorectal metastases? |
Q90102491 | ASO Author Reflections: Can Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy be Improved? |
Q36792339 | Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy |
Q64092130 | Colorectal Peritoneal Metastases: A Systematic Review of Current and Emerging Trends in Clinical and Translational Research |
Q42615377 | Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
Q48645092 | Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). |
Q36762307 | Computerized System for Staging Peritoneal Surface Malignancies |
Q44408342 | Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. |
Q47998828 | External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer |
Q40312433 | Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy |
Q26849259 | Looking up: Recent advances in understanding and treating peritoneal carcinomatosis |
Q90533514 | Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept |
Q90392289 | Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC |
Q36748744 | Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: analysis from a single oncological center |
Q46596474 | The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer |
Q50578314 | Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. |
Search more.